Kamijo Kyosuke, Nakajima Mikio, Shigemi Daisuke, Kaszynski Richard H, Ohbe Hiroyuki, Goto Tadahiro, Sasabuchi Yusuke, Fushimi Kiyohide, Matsui Hiroki, Yasunaga Hideo
Department of Gynecology, Nagano Municipal Hospital, Nagano, Japan.
Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, Tokyo, Japan.
Int J Gynaecol Obstet. 2025 Apr;169(1):341-348. doi: 10.1002/ijgo.16040. Epub 2024 Nov 18.
To elucidate the demographics, clinical characteristics, and outcomes of patients with postpartum hemorrhage (PPH) who underwent transcatheter arterial embolization (TAE).
We conducted a retrospective observational study using the Japanese Diagnosis Procedure Combination inpatient database, which covers roughly 90% of all tertiary emergency hospitals in Japan, between April 2012 to March 2020. We identified patients with PPH who underwent TAE using the Japanese medical procedure status and code, and the device or drug code. We examined the patient characteristics, interventions administered, and clinical outcomes.
Among 64 893 patients diagnosed with PPH, we identified 2705 (4.2%) patients with PPH who underwent TAE. The most common cause of PPH was uterine atony (68.7%), followed by disseminated intravascular coagulation after labor (30.0%) and placenta accreta spectrum disorders (23.4%). The proportion of patients who underwent repeat TAE and a hysterectomy was 64 (2.4%) and 188 (7.0%), respectively. Among hysterectomies (n = 188), 26 (13.8%) had the procedure performed before TAE, 73 (38.8%) underwent hysterectomy on the same day as TAE, and 89 (47.4%) had the procedure conducted after TAE. Of those who underwent a hysterectomy after TAE (n = 89), 33 (37%) were performed more than 1-week after initial TAE. Overall in-hospital mortality was 14/2705 (0.5%).
Even if hemostasis is achieved through TAE, one must be mindful that a hysterectomy may become necessary more than 1 week after the procedure. These results could be helpful in clinical decision making and providing patients with additional treatment options for PPH that preserve patient fertility.
阐明接受经导管动脉栓塞术(TAE)的产后出血(PPH)患者的人口统计学特征、临床特征及预后。
我们利用日本诊断流程组合住院患者数据库进行了一项回顾性观察研究,该数据库涵盖了日本约90%的三级急诊医院,研究时间为2012年4月至2020年3月。我们使用日本医疗程序状态和编码以及设备或药物编码来识别接受TAE的PPH患者。我们检查了患者特征、实施的干预措施和临床结局。
在64893例被诊断为PPH的患者中,我们识别出2705例(4.2%)接受TAE的PPH患者。PPH最常见的原因是子宫收缩乏力(68.7%),其次是产后弥散性血管内凝血(30.0%)和胎盘植入谱系疾病(23.4%)。接受重复TAE和子宫切除术的患者比例分别为64例(2.4%)和188例(7.0%)。在子宫切除术中(n = 188),26例(13.8%)在TAE之前进行了该手术,73例(38.8%)在TAE当天进行了子宫切除术,89例(47.4%)在TAE之后进行了该手术。在TAE后进行子宫切除术的患者中(n = 89),33例(37%)在首次TAE后1周以上进行了手术。总体住院死亡率为14/2705(0.5%)。
即使通过TAE实现了止血,也必须注意在手术后1周以上可能仍需要进行子宫切除术。这些结果可能有助于临床决策,并为PPH患者提供更多保留生育能力的治疗选择。